Nowtransit appoints John Chymboryk as CFO effective March 21, 2023

BioScience Health Innovations, Inc.

John Chymboryk appointed Chief Financial Officer, effective immediately on March 21, 2023.
Biographical details for Mr. Chymboryk were previously disclosed in a Form 8-K filed March 16, 2023.
The appointment was filed under Item 5.02 of Form 8-K.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John Chymboryk

Chief Financial Officer

BHIC · BioScience Health Innovations, Inc.

Effective: 2023-03-21
Filed: March 23, 2023, 7:59 PM ET

On March 21, 2023, Nowtransit Inc. (the “Company”) appointed Mr. John Chymboryk as Chief Financial Officer of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

John Chymboryk was appointed as Chief Financial Officer at BioScience Health Innovations, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On March 21, 2023, Nowtransit Inc. (the “Company”) appointed Mr. John Chymboryk as Chief Financial Officer of the Company, effective immediately.

View on SEC.gov

BioScience Health Innovations, Inc. filing history →

Source: SEC EDGAR

accession 0001185185-23-000249

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.